circRNA basic information
circBase ID: hsa_circ_0033393
Name: hsa_circ_HSP90A
Synonym: circ-HSP90A
Host Gene: -
Genomic location(hg19): chr14:102547074-102552461:-
Genomic location(hg38): chr14:102080737-102086124:-
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0005233
MONDO name: non-small cell lung carcinoma
Disease details: non-small cell lung cancer
Disease DO ID:
3908
Disease MeSH ID:
D002289
Disease NCIt ID:
C2926
Disease ICD11 ID:
-
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

-

Cell lines:

H1299; A549; PC9; CAL-12T; H1915; BEAS-2B; HEK293T

In vivo animal model:

-

circRNA-disease information
Expression pattern:
UP
Associated gene: ubiquitin specific peptidase 30 (USP30), HSP90A, signal transducer and activator of transcription 3 (STAT3), c-Myc, MMP2, MMP9, programmed cell death ligand 1 (PD-L1), programmed cell death 1 (PD-1)
Associated microRNA: miR-424-5p
Biological function: Circ-HSP90A promotes NSCLC cell proliferation, migration, invasion, stemness, and immune evasion, and promotes CD8 + T cells apoptosis through PD-L1.
Molecular mechanism: Circ-HSP90A recruits USP30 to de-ubiquitinate and stabilize HSP90A protein, thereby activating STAT3 signaling; it also acts as a miR-424-5p sponge to up-regulate PD-L1 and promote PD-1/PD-L1 checkpoint-mediated immune evasion.
Biological pathway or process:

JAK/STAT (promotes); proliferation (promotes); migration (promotes); invasion (promotes); stemness (promotes); immune regulation (promotes); apoptosis (promotes); ceRNA regulation (promotes); ubiquitination (inhibits)

Detected method:
Q
Validation methods:

Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Actinomycin D / DRB Stability Assay; RT-qPCR; Transfection; CCK8; Colony Formation Assay; Wound Healing Assay; Transwell Assay; Luciferase Reporter Assay; Western Blot; RNA Pull-Down; RIP (RNA Immunoprecipitation); Flow Cytometry(Non-apoptosis/cycle); Nuclear-Cytoplasmic Fractionation; FISH / smFISH; Bioinformatics Analysis

Clinical significance:

Targeting circ-HSP90A might become a novel target of immunotherapy in NSCLC.

Description:

In this study, hsa_circ_0033393/circ-HSP90A is an HSP90A-derived circRNA up-regulated in NSCLC cells. It promotes proliferation, migration, invasion, stemness, and immune evasion by recruiting USP30 to stabilize HSP90A and activate STAT3 signaling, and by sponging miR-424-5p to increase PD-L1 expression and suppress CD8 + T-cell activity.

Confidence score:

0.8093

Other information
Title:

Circ-HSP90A expedites cell growth, stemness, and immune evasion in non-small cell lung cancer by regulating STAT3 signaling and PD-1/PD-L1 checkpoint.

Journal: Cancer immunology, immunotherapy : CII
Published: 2023
PubMed ID: 35750765
Study type:

biological research

Data availability: -
Code availability: -